Zimmer Biomet Holdings, Inc. (ZBH) Financial Statements
Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies
In fiscal 2025, Zimmer Biomet reported revenue of $8.23B, up 7.2% from $7.68B the year before. Net income was $705.1M (a 8.6% net margin), or $3.55 per diluted share. Gross margin was 69.7% and operating margin was 13.3%. Operating activities generated $1.70B of cash, leaving $1.47B of free cash flow. At fiscal year end, Zimmer Biomet held $23.09B in total assets against $10.39B in total liabilities, including $591.9M of cash and equivalents.
Open the full interactive Zimmer Biomet financials → Quarterly statements, key ratios, valuation history and price charts.
Zimmer Biomet Key Stats
| Share Price | $92.08 |
|---|---|
| Market Cap | $17.75B |
| P/E Ratio | 25.9 |
| Revenue YoY Growth | +7.2% |
| 52-Week Range | $79.16 – $102.88 |
| Shares Outstanding | 192.2 million (basic, 2026 Q2) |
Zimmer Biomet Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $7.02B | $7.84B | $6.94B | $7.39B | $7.68B | $8.23B |
| Cost of Goods Sold | $2.13B | $2.34B | $2.02B | $2.08B | $2.19B | $2.49B |
| Gross Profit | $4.90B | $5.50B | $4.92B | $5.31B | $5.49B | $5.74B |
| Operating Income | -$87.8M | $780.1M | $696.3M | $1.28B | $1.29B | $1.10B |
| Pre-Tax Income | -$274.4M | $418.4M | $403.5M | $1.07B | $1.04B | $830.8M |
| Income Tax | -$137.0M | $16.3M | $112.3M | $42.2M | $131.4M | $125.7M |
| Net Income | -$138.9M | $401.6M | $231.4M | $1.02B | $903.8M | $705.1M |
| Diluted EPS | -$0.65 | $1.85 | $1.10 | $4.88 | $4.43 | $3.55 |
Zimmer Biomet Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $2.00B | $2.24B | $2.09B | $2.18B |
| Net Income | $230.9M | $139.4M | $238.1M | $198.3M |
| Diluted EPS | $1.16 | $0.70 | $1.22 | $1.03 |
Zimmer Biomet Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $802.1M | $478.5M | $375.7M | $415.8M | $525.5M | $591.9M |
| Current Assets | $5.08B | $4.88B | $4.43B | $4.61B | $4.67B | $5.12B |
| Total Assets | $24.42B | $23.46B | $21.07B | $21.50B | $21.37B | $23.09B |
| Current Liabilities | $2.56B | $3.47B | $2.36B | $2.86B | $2.45B | $2.58B |
| Total Long-Term Debt | $8.13B | $7.07B | $5.70B | $5.77B | $6.20B | $7.52B |
| Total Liabilities | $12.22B | $10.79B | $9.04B | $9.01B | $8.89B | $10.39B |
| Shareholders' Equity | $12.19B | $12.66B | $12.02B | $12.48B | $12.47B | $12.70B |
Zimmer Biomet Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $1.20B | $1.50B | $1.36B | $1.58B | $1.50B | $1.70B |
| Cash From Investing | -$613.8M | -$503.6M | — | — | — | -$1.98B |
| Cash From Financing | -$421.8M | -$1.31B | — | — | — | $326.0M |
| Free Cash Flow | $1.09B | $1.33B | $1.17B | $1.29B | $1.30B | $1.47B |
Figures from Zimmer Biomet's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Zimmer Biomet financials page for every line item.
Zimmer Biomet Company Profile
| Ticker | ZBH |
|---|---|
| Exchange | NYSE |
| Industry | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Headquarters | Warsaw, Indiana |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001136869 |
Frequently Asked Questions
What was Zimmer Biomet's revenue in fiscal 2025?
Zimmer Biomet (ZBH) reported revenue of $8.23B for fiscal 2025.
What is Zimmer Biomet's annual revenue history?
Zimmer Biomet's annual revenue by fiscal year: 2020: $7.02B; 2021: $7.84B; 2022: $6.94B; 2023: $7.39B; 2024: $7.68B; 2025: $8.23B.
What was Zimmer Biomet's net income in fiscal 2025?
Zimmer Biomet reported net income of $705.1M for fiscal 2025.
What was Zimmer Biomet's earnings per share (EPS) in fiscal 2025?
Zimmer Biomet's diluted EPS was $3.55 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Zimmer Biomet generate in fiscal 2025?
Zimmer Biomet generated $1.47B of free cash flow in fiscal 2025.
What was Zimmer Biomet's revenue last quarter?
In its most recent reported quarter (2026 Q2), Zimmer Biomet reported revenue of $2.18B.
How much debt does Zimmer Biomet have?
Zimmer Biomet reported $7.52B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Zimmer Biomet are outstanding?
Zimmer Biomet reported a weighted average of 192.2 million basic shares outstanding in 2026 Q2.
What is Zimmer Biomet's market cap?
Based on its latest closing price, Zimmer Biomet (ZBH) has a market capitalization of about $17.75B.
When does Zimmer Biomet's fiscal year end?
Zimmer Biomet's fiscal year end, as registered with the SEC, is December 31.
Where is Zimmer Biomet headquartered?
Zimmer Biomet lists its business address in Warsaw, Indiana in its SEC filings.
Zimmer Biomet Competitors & Similar Companies
See all 20 Orthopedic, Prosthetic & Surgical Appliances & Supplies companies →